Hillsdale Investment Management Inc. Ani Pharmaceuticals Inc Transaction History

Hillsdale Investment Management Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$58.53 - $68.82 $3.95 Million - $4.64 Million	-67,420 Reduced 99.87%	90 $5,000
Q1 2024 May 10, 2024	SELL	$54.2 - $69.69 $102,980 - $132,411	-1,900 Reduced 2.74%	67,510 $4.67 Million
Q4 2023 Feb 09, 2024	SELL	$48.72 - $65.43 $9,256 - $12,431	-190 Reduced 0.27%	69,410 $3.83 Million
Q3 2023 Nov 09, 2023	BUY	$50.28 - $64.61 $3.5 Million - $4.49 Million	69,520 Added 86900.0%	69,600 $4.04 Million
Q2 2023 Aug 11, 2023	BUY	$37.29 - $53.83 $2,983 - $4,306	80 New	80 $4,000

212

18.8M

11.7K

10.5K

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $982M
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

Get notified when there are updates to the investment portfolio of Hillsdale Investment Management Inc., based on Form 13F filings with the SEC.

Stay updated on Hillsdale Investment Management Inc. with notifications on news.